Open AccessA population-based comparison of treatment patterns, resource utilization, and costs by cancer stage for Ontario patients with hormone receptor-positive/HER2-negative breast cancer
Author(s) -
Christine Brezden-Masley,
Kelly E. Fathers,
Megan Coombes,
Behin Pourmirza,
Cloris Xue,
Katarzyna J. Jerzak
Publication year - 2020
Publication title -
breast cancer research and treatment
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.908
H-Index - 154
eISSN - 1573-7217
pISSN - 0167-6806
DOI - 10.1007/s10549-020-05960-4
Subject(s) - medicine , breast cancer , lumpectomy , population , cancer , cohort , stage (stratigraphy) , cancer registry , health care , oncology , gynecology , mastectomy , environmental health , biology , paleontology , economics , economic growth
To update and expand on data related to treatment, resource utilization, and costs by cancer stage in Canadian patients with hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) breast cancer (BC).